Reimer, Francesca
Bryan, Sarah
Legler, Karen
Karn, Thomas
Eppenberger-Castori, Serenella
Matschke, Jakob
Pereira-Veiga, Thais
Wikman, Harriet
Witzel, Isabell
Müller, Volkmar
Schmalfeldt, Barbara
Milde-Langosch, Karin
Schumacher, Udo
Stürken, Christine
Oliveira-Ferrer, Leticia
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 15 December 2022
Accepted: 9 March 2023
First Online: 16 March 2023
Declarations
:
: All patients gave written approval for the utilisation of their tissue samples and the reviewing of their medical records according to our investigational review board and ethics committee guidelines (Ethik-Kommission der Ärztekammer Hamburg, #OB/V/03). The animal study protocol was approved by the Behörde für Gesundheit und Verbraucherschutz of Freie und Hansestadt Hamburg (N005/2020; 12.03.2020).
: Not applicable.
: The authors declare no conflict of interest concerning the presented analysis. IW received speaker´s honoraria outside this work from Amgen, Astra Zeneca, Daiichi-Sankyo, Lilly, MSD, Novar-tis, Pierre Fabre, Pfizer, Roche, and Seagen. VM received speaker’s honoraria from Amgen, Astra Zeneca, Daiichi-Sankyo, Eisai, GSK, Pfizer, MSD, Medac, Novartis, Roche, Teva, Seagen, Onkowissen, high5 Oncology, Medscape, Gilead, Pierre Fabre; consultancy honoraria from Hexal, Roche, Pierre Fabre, Amgen, ClinSol, Novartis, MSD, Daiichi-Sankyo, Eisai, Lilly, Sanofi, Seagen, Gilead; institutional research support from Novartis, Roche, Seagen, Genentech and travel grants from Roche, Pfizer, Daiichi Sankyo, Gilead.BS received speaker´s honoraria, travel grants and consultancy honoraria as well as institutional research support outside this work from Eisai, Astra Zeneca, MSD, Pfizer, Roche, GSK, Clovis, and Ethicon. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results”.